However, our study model was restricted to normal physiological conditions, and more experiments are required to understand whether FGF1 will have any antiarrhythmic effect under more complex pathological conditions (such as Ca2+ overload, oxidative stress, or ischemia). The gene discussed is FGF1; the disease is ischemia.